在人类红细胞前体HUDEP-2细胞中调节BCL11ADNA结合和表达
bioRxiv : the preprint server for biology
|March 13, 2026
概括
BCL11A是血红蛋白切换的关键因素,也是血液疾病的治疗点. 这项研究阐明了它的DNA结合,表观遗传调节,以及小分子如何影响它的网络,提供了新的HbF重新激活策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- BCL11A是神经发育和血液形成的关键转录因子.
- 它调节从胎儿血红蛋白 (HbF) 转换为成人血红蛋白.
- BCL11A是状细胞疾病和β-thalassemia的重要治疗标.
研究的目的:
- 研究BCL11A的功能,包括其DNA识别机制.
- 探索影响BCL11A表达和HbF水平的表观遗传修饰.
- 分析波马利多米德和莱纳利多米德衍生物化合物对BCL11A调控网络的影响.
主要方法:
- 通过使用DNA结合试验,通过BCL11A异型 (L和XL) 检查DNA识别.
- 用表观遗传抑制剂 (DNA甲基化,H3K9me,H3K27me) 治疗HUDEP-2细胞以评估HbF表达.
- 选了213种波马利多米德/莱纳利多米德类似物,并通过流细胞计和质谱学分析了化合物效应.
主要成果:
- BCL11A优先结合6bpDNA基因TGNCCA,在ZF4-6和ZF2-3域中观察到不同的链特异相互作用.
- 表观遗传沉默标记抑制剂增加了HbF表达;FTX6058减少了BCL11A转录/翻译,而EML741导致了部分减少.
- 四种选化合物降低了IKZF1和ZFP91水平,但没有改变BCL11A水平,这表明网络调制.
结论:
- 澄清了BCL11ADNA识别以及多个指阵列在结合中的作用.
- 证明表观遗传调制可以重新激活HbF表达.
- 表明小分子降解剂可以影响BCL11A调节网络,为HbF重新激活提供治疗途径.
相关概念视频
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
Master Transcription Regulators
8.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
General Transcription Factors
7.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.4K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Negative Regulator Molecules
38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K


